AlphaMark Advisors’s Johnson & Johnson JNJ Stock Holding History

AlphaMark Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$250K	Buy	1,729 +361	+26%	+$55.9K	0.11%	113
2024 Q3	$222K	Sell	1,368 -149	-10%	-$23.7K	0.08%	218
2024 Q2	$222K	Buy	1,517 +76	+5%	+$11.3K	0.08%	221
2024 Q1	$228K	Sell	1,441 -2,256	-61%	-$359K	0.08%	218
2023 Q4	$580K	Sell	3,697 -306	-8%	-$46.9K	0.22%	65
2023 Q3	$624K	Sell	4,003 -539	-12%	-$88.9K	0.27%	58
2023 Q2	$752K	Buy	4,542 +222	+5%	+$35.8K	0.35%	53
2023 Q1	$670K	Buy	4,320 +175	+4%	+$28.3K	0.3%	59
2022 Q4	$732K	Sell	4,145 -254	-6%	-$43.9K	0.37%	52
2022 Q3	$719K	Sell	4,399 -619	-12%	-$105K	0.36%	50
2022 Q2	$891K	Buy	5,018 +1	+0%	+$178	0.41%	51
2022 Q1	$889K	Sell	5,017 -601	-11%	-$102K	0.33%	59
2021 Q4	$961K	Sell	5,618 -193	-3%	-$31.6K	0.34%	58
2021 Q3	$938K	Sell	5,811 -199	-3%	-$34K	0.34%	56
2021 Q2	$990K	Sell	6,010 -175	-3%	-$29K	0.36%	55
2021 Q1	$1.02M	Buy	6,185 +384	+7%	+$62.1K	0.39%	52
2020 Q4	$913K	Sell	5,801 -99	-2%	-$14.6K	0.35%	54
2020 Q3	$878K	Hold	5,900	–	–	0.36%	55
2020 Q2	$830K	Sell	5,900 -41	-0.7%	-$5.97K	0.36%	52
2020 Q1	$779K	Buy	5,941 +142	+2%	+$20.1K	0.43%	47
2019 Q4	$846K	Buy	5,799 +75	+1%	+$10.2K	0.35%	55
2019 Q3	$741K	Sell	5,724 -680	-11%	-$89.6K	0.32%	55
2019 Q2	$892K	Hold	6,404	–	–	0.39%	52
2019 Q1	$895K	Sell	6,404 -50	-0.8%	-$6.7K	0.38%	55
2018 Q4	$833K	Sell	6,454 -180	-3%	-$25.1K	0.4%	52
2018 Q3	$917K	Hold	6,634	–	–	0.37%	55
2018 Q2	$805K	Sell	6,634 -130	-2%	-$16.2K	0.33%	68
2018 Q1	$867K	Buy	6,764 +2,314	+52%	+$313K	0.37%	59
2017 Q4	$622K	Sell	4,450 -520	-10%	-$72.4K	0.24%	72
2017 Q3	$646K	Sell	4,970 -22	-0.4%	-$2.92K	0.27%	68
2017 Q2	$660K	Sell	4,992 -253	-5%	-$32.3K	0.28%	72
2017 Q1	$653K	Hold	5,245	–	–	0.3%	69
2016 Q4	$604K	Buy	5,245 +390	+8%	+$45K	0.31%	66
2016 Q3	$574K	Sell	4,855 -250	-5%	-$30.3K	0.29%	71
2016 Q2	$619K	Hold	5,105	–	–	0.37%	67
2016 Q1	$552K	Buy	5,105 +222	+5%	+$23K	0.29%	68
2015 Q4	$502K	Hold	4,883	–	–	0.26%	74
2015 Q3	$456K	Buy	4,883 +95	+2%	+$9.19K	0.25%	72
2015 Q2	$467K	Buy	4,788 +100	+2%	+$10K	0.26%	73
2015 Q1	$472K	Buy	4,688 +100	+2%	+$10.2K	0.26%	71
2014 Q4	$480K	Hold	4,588	–	–	0.3%	69
2014 Q3	$489K	Hold	4,588	–	–	0.31%	69
2014 Q2	$480K	Sell	4,588 -20	-0.4%	-$2.02K	0.29%	73
2014 Q1	$453K	Sell	4,608 -195	-4%	-$18.1K	0.28%	74
2013 Q4	$440K	Buy	4,803 +175	+4%	+$16.1K	0.27%	77
2013 Q3	$401K	Hold	4,628	–	–	0.25%	77
2013 Q2	$397K	Buy	+4,628	New	+$393K	0.24%	77

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AlphaMark Advisors's JNJ Position: Q4 2024 in Review

AlphaMark Advisors increased its Johnson & Johnson (JNJ) stake by 26% in Q4 2024, buying an estimated $55.9K and bringing the position to 1,729 shares worth $250K. The position accounts for 0.11% of the portfolio, ranked #113.

AlphaMark Advisors first reported a position in JNJ in Q2 2013 and has held it in 47 quarters since. The position peaked at $1.02M in Q1 2021. 4,105 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

AlphaMark Advisors held 1,729 shares of Johnson & Johnson worth $250K as of Q4 2024.
AlphaMark Advisors bought 361 Johnson & Johnson shares in Q4 2024, an estimated $55.9K.
Johnson & Johnson made up 0.11% of AlphaMark Advisors's portfolio in Q4 2024, its #113 holding.
AlphaMark Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 47 quarters since.
AlphaMark Advisors's Johnson & Johnson position peaked at $1.02M in Q1 2021.
4,105 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.